Alembic Pharma JV Aleor gets USFDA nod for generic antifungal cream

New Delhi: Drug firm Alembic Pharmaceuticals on Thursday said its joint venture Aleor Dermaceuticals has received final nod from the US health regulator for antifungal Nystatin and Triamcinolone Acetonide cream used for the treatment of cutaneous candidiasis. Aleor Dermaceuticals Ltd (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Nystatin and Triamcinolone Acetonide cream USP, 1,00,000 units/gram and 1 mg/gram, Alembic Pharma said in a BSE filing.

The product is a generic version of Taro Pharmaceuticals USA Inc’s Nystatin and Triamcinolone Acetonide cream USP in the same strength, it added.

According to IQVIA, Nystatin and Triamcinolone Acetonide cream USP has an estimated market size of USD 19 million for twelve months ending December 2020, the filing said.

  • Related Posts

    Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

    Chandigarh: In a major push to strengthen public healthcare, the Haryana Government has directed all government hospitals to maintain medicine stock records on a real-time centralised portal, ensuring transparency and…

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    New Delhi: The Parliamentary Panel on Health and Family Welfare has recommended various significant regulatory changes in the regulation of medical devices, including decentralisation of approval for all medical devices…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

    Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority